ClinicalTrials.Veeva

Menu

Cytomegalovirus (CMV) Transmission by Frozen Breast Milk in Preterms

J

Johann Wolfgang Goethe University Hospital

Status

Suspended

Conditions

Cytomegalovirus

Study type

Observational

Funder types

Other

Identifiers

NCT00668798
CMV/MM0105/FFM

Details and patient eligibility

About

Cytomegalovirus infection threatens preterm infant. We investigated, whether thawed breast milk is a mode of transmission

Full description

Preterm infants are at risk of symptomatic human cytomegalovirus infections transmitted by breast milk. This study evaluates incidence, timing, and clinical rlevance of acquired human CMV infections in preterm infants younger than 32 weeks of gestational age receiving maternal thawed frozen breast milk until 33 completed weeks of gestational age.

Enrollment

58 patients

Sex

All

Ages

24 to 31 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • preterm infants of less than 32 weeks of gestation

Exclusion criteria

  • preterm infant of 32 weeks of gestational age or older, feeding with solely formula milk
  • ourborn infants
  • retroviral infection
  • CMV status of mother unclear
  • informed consent missing

Trial design

58 participants in 2 patient groups

A
Description:
mother CMV positive
B
Description:
mother CMV negative

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems